Loss of TSC complex enhances gluconeogenesis via upregulation of <i>Dlk1-Dio3</i> locus miRNAs.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 31919282.
- Also identified by DOI 10.1073/pnas.1918931117 and PMC identifier 6983401.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Loss of the tumor suppressor tuberous sclerosis complex 1 (<i>Tsc1</i>) in the liver promotes gluconeogenesis and glucose intolerance. We asked whether this could be attributed to aberrant expression of small RNAs. We performed small-RNA sequencing on liver of <i>Tsc1</i>-knockout mice, and found that miRNAs of the delta-like homolog 1 (<i>Dlk1</i>)-deiodinase iodothyronine type III (<i>Dio3</i>) locus are up-regulated in an mTORC1-dependent manner. Sustained mTORC1 signaling during development prevented CpG methylation and silencing of the <i>Dlk1-Dio3</i> locus, thereby increasing miRNA transcription. Deletion of miRNAs encoded by the <i>Dlk1-Dio3</i> locus reduced gluconeogenesis, glucose intolerance, and fasting blood glucose levels. Thus, miRNAs contribute to the metabolic effects observed upon loss of TSC1 and hyperactivation of mTORC1 in the liver. Furthermore, we show that miRNA is a downstream effector of hyperactive mTORC1 signaling.
Medical subject headings
- Calcium-Binding Proteins
- Gluconeogenesis
- Iodide Peroxidase
- MicroRNAs
- Tuberous Sclerosis Complex 1 Protein
- Up-Regulation